Internal Medicine, Rheumatology · New York, NY
NPI
1215031521
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
1088 Park Avenue
New York, NY, 10128
Phone (212) 860-2100
Medicare paid, 2023
$54K
775 services
Medicare patients, 2023
361
Average age 73
Drug cost, 2024
$2.6M
1,519 prescriptions
Company payments, 2025
$16K
From 8 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Robert F Spiera was code 99214 (office e&m - established), 432 times for 311 patients. In total Robert F Spiera billed 775 services in 11 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 432 | 311 | $100.65 | $43K |
| 36415 Venipuncture Blood Collection | Office | 262 | 199 | $8.40 | $2,201 |
| 99204 Office E&M - New | Office | 44 | 44 | $133.50 | $5,874 |
| 99213 Office E&M - Established | Office | 16 | 16 | $59.69 | $955 |
By year: 2022 $92K for 1,268 services; 2023 $54K for 775 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 262 | 199 | $8.40 | $2,201 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert F Spiera prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 194 prescriptions and refills. In total Robert F Spiera wrote 1,519 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 194 | 286 | 36 | $4,775 |
| Hydroxychloroquine Sulfate Generic | 173 | 345 | 54 | $5,681 |
| Prednisone Generic | 100 | 149 | 27 | $1,600 |
| Methylprednisolone Generic | 87 | 96 | 41 | $1,770 |
| Enbrel Sureclick Etanercept | 78 | 78 | Under 11 | $614K |
| Humira(Cf) Pen Adalimumab | 64 | 77 | Under 11 | $749K |
| Folic Acid Generic | 64 | 88 | Under 11 | $399 |
| Colchicine Generic | 60 | 82 | 14 | $6,525 |
| Leflunomide Generic | 40 | 79 | Under 11 | $2,033 |
| Alendronate Sodium Generic | 38 | 56 | Under 11 | $243 |
| Rinvoq Upadacitinib | 34 | 34 | Under 11 | $208K |
| Mycophenolate Mofetil Generic | 32 | 64 | Under 11 | $5,741 |
| Enbrel Etanercept | 29 | 47 | Under 11 | $357K |
| Gabapentin Generic | 27 | 50 | Under 11 | $320 |
| Cevimeline Hcl Generic | 26 | 54 | Under 11 | $5,849 |
Brand drugs: - claims; generic drugs: 1,167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert F Spiera $16K ($10K in general payments such as food, travel and fees and $6,300 for research) from 8 companies. The largest payer was Galderma Laboratories, L.P. with $6,795.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.